111897-11-1 Usage
Uses
Used in Pharmaceutical and Chemical Research:
4-[3-(2-FURYL)-1H-PYRAZOL-5-YL]PIPERIDINE is used as a building block for the synthesis of other organic compounds, contributing to the development of new pharmaceutical agents and chemical products. Its unique structure allows for versatile chemical modifications, enhancing its utility in creating novel compounds with potential therapeutic or industrial applications.
Used in Coordination Chemistry:
In the field of coordination chemistry, 4-[3-(2-FURYL)-1H-PYRAZOL-5-YL]PIPERIDINE is used as a ligand, playing a crucial role in the formation of coordination complexes. Its ability to chelate with metal ions can lead to the development of new materials with specific properties, such as catalysts, sensors, or materials with magnetic and electronic characteristics.
Used in Biological Activity Studies:
4-[3-(2-FURYL)-1H-PYRAZOL-5-YL]PIPERIDINE is used in biological activity studies to explore its potential pharmacological properties. Given its structural components, it may exhibit bioactivity that could be harnessed for therapeutic purposes, warranting investigation into its effects on biological systems and its interaction with biological targets.
Used in Drug Development:
4-[3-(2-FURYL)-1H-PYRAZOL-5-YL]PIPERIDINE may be utilized in drug development as a lead compound or a component of drug candidates. Its unique structure could provide a foundation for the design of new drugs with specific therapeutic targets, potentially leading to the discovery of novel treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 111897-11-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,8,9 and 7 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 111897-11:
(8*1)+(7*1)+(6*1)+(5*8)+(4*9)+(3*7)+(2*1)+(1*1)=121
121 % 10 = 1
So 111897-11-1 is a valid CAS Registry Number.
111897-11-1Relevant articles and documents
DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS
-
, (2012/02/15)
The present invention relates to new drug combinations which contain in addition to one or more PDE4-inhibitors at least one NSAID (=non-steroidal anti-inflammatory drug) (2), processes for preparing them and their use in treating in particular respiratory complaints such as for example COPD, chronic sinusitis and asthma. The invention particularly relates to those drug combinations which contain, in addition to one or more, preferably one PDE4 inhibitor of general formula 1 wherein X is SO or SO2, but preferably SO, and wherein R1, R2, R3 and R4 have the meanings given in claim 1, at least one NSAID (2), the preparation thereof and the use thereof for the treatment of respiratory complaints.